Life Sciences

Articles - Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs).

Short Reads - The draft temporary bill on Expedited Liquidation Transparency presented by the Dutch Minister of Justice on 28 June 2021 aims to increase transparency, improve protection of creditors and reduce the risk of abuse. We expect that this bill could be in effect indefinitely, as the issues it addresses were pressing long before COVID-19.

Seminar - Philippe Campolini, partner in our IP department and board member of EPLAW (the European Patent Lawyers Association), is panelist during a webinar on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Short Reads - On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.

Articles - Recent efforts by the Dutch government to amend the tax treatment of stock option plans are examined by Charlotte Tolman and Michael Molenaars in this article in Tax Notes International. The proposed changes are welcome, but might not solve all liquidity concerns.

Short Reads - Een risico-inventarisatie en -evaluatie met bijbehorend plan is verplicht voor iedere werkgever, maar veel werkgevers hebben deze niet. In dit blog gaan we in op de inhoud en achtergrond van de RI&E en op de risico's voor werkgevers die geen RI&E hebben.

Articles - Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.   

Short Reads - The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.